20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Importance of High Purity APIs in Modern Pharmaceutical Development

In the pharmaceutical industry, the quality of Active Pharmaceutical Ingredients (APIs) is the bedrock of drug safety and therapeutic efficacy. NINGBO INNO PHARMCHEM CO.,LTD. places paramount importance on supplying APIs that meet the most stringent purity standards, exemplified by products such as Canagliflozin Hemihydrate. Understanding why high purity matters is essential for any pharmaceutical development strategy.

High purity in an API signifies a minimal presence of impurities, which can include residual starting materials, by-products from synthesis, or degradation products. Even trace amounts of certain impurities can have significant implications for a drug's safety profile, potentially leading to adverse reactions, reduced potency, or altered pharmacokinetic properties. For complex molecules like Canagliflozin Hemihydrate, a precise chemical structure is vital for its intended pharmacological action as an SGLT2 inhibitor. Deviations from this structure, introduced by impurities, can compromise its effectiveness in managing type 2 diabetes, its cardiovascular benefits, or its impact on kidney function.

The development and manufacturing processes for APIs like Canagliflozin Hemihydrate are rigorously controlled to ensure the highest levels of purity. This involves sophisticated analytical techniques at every stage of production, from raw material sourcing to final product testing. Certifications such as GMP (Good Manufacturing Practices) are not merely regulatory checkboxes; they are fundamental to guaranteeing that each batch of API consistently meets predefined quality specifications. For companies aiming to bring effective and safe treatments to market, choosing an API supplier with a proven track record in purity assurance is non-negotiable.

NINGBO INNO PHARMCHEM CO.,LTD.'s commitment to providing Canagliflozin Hemihydrate with purity exceeding 99% ensures that our partners can develop reliable and effective medications. This dedication to quality is a cornerstone of our contribution to advancing pharmaceutical development and ensuring better health outcomes for patients worldwide. When considering pharmaceutical ingredient sourcing strategies, the emphasis on high purity APIs should always be a primary consideration.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Leveraging Canagliflozin Hemihydrate for Cardiovascular Risk Reduction in Type 2 Diabetes

Next: Navigating Regulatory Landscapes: Ensuring Compliance with Canagliflozin Hemihydrate

All Rights Reserved